Cited by 2,149Multiple Sclerosis Research StudiesT-cell and B-cell ImmunologyPsoriasis: Treatment and Pathogenesis

The DOI matches its Crossref record; 362 of the 362 references it cites were found in a registry or an index.

IMMUNOLOGY OF MULTIPLE SCLEROSIS

Sospedra, Mireia, Martin, Roland·2005·Annual Review of Immunology

DOI 10.1146/annurev.immunol.23.021704.115707

Open this paper in CoChat — free account

Abstract

Multiple sclerosis (MS) develops in young adults with a complex predisposing genetic trait and probably requires an inciting environmental insult such as a viral infection to trigger the disease. The activation of CD4+ autoreactive T cells and their differentiation into a Th1 phenotype are a crucial events in the initial steps, and these cells are probably also important players in the long-term evolution of the disease. Damage of the target tissue, the central nervous system, is, however, most likely mediated by other components of the immune system, such as antibodies, complement, CD8+ T cells, and factors produced by innate immune cells. Perturbations in immunomodulatory networks that include Th2 cells, regulatory CD4+ T cells, NK cells, and others may in part be responsible for the relapsing-remitting or chronic progressive nature of the disease. However, an important paradigmatic shift in the study of MS has occurred in the past decade. It is now clear that MS is not just a disease of the immune system, but that factors contributed by the central nervous system are equally important and must be considered in the future.

Integrity signals

Registry

Crossref · 10.1146/annurev.immunol.23.021704.115707

Cites

362 of 362 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells
Pasare, C., & Medzhitov, R. M. (2003) · Science · doi:10.1126/science.1078231 · Cited by 2,000
Use of a cDNA microarray to analyse gene expression patterns in human cancer
DeRisi, J. L., Penland, L., Brown, P. O., Bittner, M. L., Meltzer, P. S., Ray, M., Chen, Y.-W., Su, Y. A., & Trent, J. M. (1996) · Nature Genetics · doi:10.1038/ng1296-457 · Cited by 1,952
Counting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
Murali‐Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J. E., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80470-7 · Cited by 1,918
Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
Viglietta, V., Baecher‐Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,858
Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo
Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M. N., Ravetch, J. V., Steinman, R. M., & Nussenzweig, M. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.769 · Cited by 1,848
Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease
Monney, L., Sabatos, C. A., Gaglia, J. L., Ryu, A., Waldner, H., Chernova, T., Manning, S., Greenfield, E. A., Coyle, A. J., Sobel, R. A., et al. (2002) · Nature · doi:10.1038/415536a · Cited by 1,683
Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis
Johnson, K., Brooks, B., Cohen, J. A., Ford, C., Goldstein, J., Lisak, R., Myers, L., Panitch, H., Rose, J., Schiffer, R., et al. (1995) · Neurology · doi:10.1212/wnl.45.7.1268 · Cited by 1,667

Show all 362 references

Research works printed but not linked: 12

McFarland HF, 1999, Am. J. Neuroradiol., 20, 1777
10.1172/JCI200421357 · DOI
Charcot J, 1868, Gaz. Hopitaux, 41, 554
Remlinger J, 1905, Ann. Inst. Pasteur, 19, 625
Berger T, 1997, Lab. Invest., 76, 355
10.1097/00019052-200306000-00004 · DOI
Sharief MK, 1991, Brain, 114, 181
Bornstein MB, 1959, Trans. Am. Neurol. Assoc., 84, 165
10.1002/1531-8249(200006)47:6<694::AID-ANA2>3.0.CO;2-W · DOI
Linington C, 1988, Am. J. Pathol., 130, 443
Benczur M, 1980, Clin. Exp. Immunol., 39, 657
10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-# · DOI

Sorted by citations

Items 301–400 of 1,006

Multiple sclerosis: Serum-derived exosomes express myelin proteins
Gałązka, G., Mycko, M. P., Selmaj, I., Raine, C. S., & Selmaj, K. W. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458517696597 · Cited by 103
Neuroprotection and Remyelination after Autoimmune Demyelination in Mice that Inducibly Overexpress CXCL1
Omari, K. M., Lutz, S. E., Santambrogio, L., Lira, S. A., & Raine, C. S. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080350 · Cited by 103
IL-33 blockade suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice
Li, M., Li, Y., Liu, X., Gao, X., & Wang, Y. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.03.016 · Cited by 106
TASK1 modulates inflammation and neurodegeneration in autoimmune inflammation of the central nervous system
Bittner, S., Meuth, S. G., Göbel, K., Melzer, N., Herrmann, A. M., Simon, O. J., Weishaupt, A., Budde, T., Bayliss, D. A., Bendszus, M., et al. (2009) · Brain · doi:10.1093/brain/awp163 · Cited by 106
Stromal Interaction Molecules 1 and 2 Are Key Regulators of Autoreactive T Cell Activation in Murine Autoimmune Central Nervous System Inflammation
Schuhmann, M. K., Stegner, D., Berna‐Erro, A., Bittner, S., Braun, A., Kleinschnitz, C., Stoll, G., Wiendl, H., Meuth, S. G., & Nieswandt, B. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902161 · Cited by 104
From genes to function: the next challenge to understanding multiple sclerosis
Fugger, L. H., Friese, M. A., & Bell, J. I. (2009) · Nature reviews. Immunology · doi:10.1038/nri2554 · Cited by 105
Functional genomics analysis of vitamin D effects on CD4+ T cells in vivo in experimental autoimmune encephalomyelitis
Zeitelhofer, M., Adzemovic, M. Z., Gómez-Cabrero, D., Bergman, P., Hochmeister, S., N’diaye, M., Paulson, A., Ruhrmann, S., Almgren, M., Tegner, J. N., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1615783114 · Cited by 112
The immunogenetics of multiple sclerosis
Svejgaard, A. (2008) · Immunogenetics · doi:10.1007/s00251-008-0295-1 · Cited by 105
Stress and hypothalamic–pituitary–adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis—A review
Heesen, C., Gold, S. M., Huitinga, I., & Reul, J. M. H. M. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.05.002 · Cited by 105
Contribution of Astrocyte-Derived IL-15 to CD8 T Cell Effector Functions in Multiple Sclerosis
Saikali, P., Antel, J. P., Pittet, C. L., Newcombe, J., & Arbour, N. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002188 · Cited by 101
Epigallocatechin-3-Gallate Ameliorates Experimental Autoimmune Encephalomyelitis by Altering Balance among CD4+ T-Cell Subsets
Wang, J., Ren, Z., Xu, Y., Xiao, S., Meydani, S. N., & Wu, D. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.09.007 · Cited by 103
Malat1 long noncoding RNA regulates inflammation and leukocyte differentiation in experimental autoimmune encephalomyelitis
Masoumi, F., Ghorbani, S., Talebi, F., Branton, W. G., Rajaei, S., Power, C., & Noorbakhsh, F. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.11.013 · Cited by 101
Biphasic Mechanisms of Neurovascular Unit Injury and Protection in CNS Diseases
Maki, T., Hayakawa, K., Pham, L. D., Xing, C., Lo, E. H., & Arai, K. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527311312030004 · Cited by 103
Role of Cytokines as Mediators and Regulators of Microglial Activity in Inflammatory Demyelination of the CNS
Merson, T. D., Binder, M. D., & Kilpatrick, T. J. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8112-z · Cited by 84
The Roles of Neutrophils in Cytokine Storms
Chan, L., Karimi, N., Morovati, S., Alizadeh, K., Kakish, J. E., Vanderkamp, S., Fazel, F., Napoleoni, C., Alizadeh, K., Mehrani, Y., et al. (2021) · Viruses · doi:10.3390/v13112318 · Cited by 102
Plasma endocannabinoid levels in multiple sclerosis
Jean-Gilles, L., Feng, S., Tench, C. R., Chapman, V., Kendall, D. A., Barrett, D. A., & Constantinescu, C. S. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.07.021 · Cited by 100
Role of IL-15 in immune-mediated and infectious diseases
Sabatino, A. D., Calarota, S. A., Vidali, F., MacDonald, T. T., & Corazza, G. R. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.09.003 · Cited by 100
Epstein-Barr Virus: Environmental Trigger of Multiple Sclerosis?
Lünemann, J. D., Kamradt, T., Martinꝉ, R., & Münz, C. (2007) · Journal of Virology · doi:10.1128/jvi.00153-07 · Cited by 100
Self-citation
Mechanisms of oligodendrocyte regeneration from ventricular-subventricular zone-derived progenitor cells in white matter diseases
Maki, T., Liang, A. C., Miyamoto, N., Lo, E. H., & Arai, K. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00275 · Cited by 99
Role of autophagy in the pathogenesis of multiple sclerosis
Liang, P., & Le, W. (2015) · Neuroscience Bulletin · doi:10.1007/s12264-015-1545-5 · Cited by 102
Pituitary adenylyl cyclase-activating polypeptide is an intrinsic regulator of Treg abundance and protects against experimental autoimmune encephalomyelitis
Tan, Y., Abad, C., Lopez, R., Dong, H., Liu, S., Lee, A. W., Gomariz, R. P., Leceta, J., & Waschek, J. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812257106 · Cited by 99
MIF and D-DT are potential disease severity modifiers in male MS subjects
Benedek, G., Meza‐Romero, R., Jordan, K. R., Zhang, Y., Nguyen, H., Kent, G., Li, J., Siu, E., Frazer, J., Piecychna, M., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1712288114 · Cited by 99
Win odds: An adaptation of the win ratio to include ties
Brunner, E., Vandemeulebroecke, M., & Mütze, T. (2021) · Statistics in Medicine · doi:10.1002/sim.8967 · Cited by 99
Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53
Rossi, S., Motta, C., Studer, V., Macchiarulo, G., Volpe, E., Barbieri, F. R., Ruocco, G., Buttari, F., Finardi, A., Mancino, R., et al. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-56 · Cited by 102
Regulation of Immune Cell Entry into the Central Nervous System
Engelhardt, B. (2006) · Springer eBooks · doi:10.1007/400_020 · Cited by 99
Beneficial Effects of Spirulina Consumption on Brain Health
Trotta, T., Porro, C., Cianciulli, A., & Panaro, M. A. (2022) · Nutrients · doi:10.3390/nu14030676 · Cited by 98
Apoptosis signal-regulating kinase 1 as a therapeutic target
Kawarazaki, Y., Ichijo, H., & Naguro, I. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.896903 · Cited by 98
Alemtuzumab in the long-term treatment of relapsing-remitting multiple sclerosis: an update on the clinical trial evidence and data from the real world
Ziemssen, T., & Thomas, K. (2017) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285617722706 · Cited by 98
Emerging role of mesenchymal stromal cells (MSCs)-derived exosome in neurodegeneration-associated conditions: a groundbreaking cell-free approach
Yari, H., Mikhailova, M. V., Mardasi, M., Jafarzadehgharehziaaddin, M., Shahrokh, S., Thangavelu, L. P., Ahmadi, H., Shomali, N., Yaghoubi, Y., Zamani, M., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03122-5 · Cited by 98
Prevention of autoimmune disease by induction of tolerance to Toll-like receptor 7
Hayashi, T., Gray, C. S., Chan, M., Tawatao, R. I., Ronacher, L., McGargill, M. A., Datta, S. K., Carson, D. A., & Corr, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813037106 · Cited by 98
Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis
Correale, J. D., & Villa, A. M. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.12.004 · Cited by 102
Role of toll-like receptors in multiple sclerosis.
Miranda‐Hernandez, S., & Baxter, A. G. (2013) · Europe PMC (PubMed Central) · Cited by 96
Cytotoxic CD4+ T Cells Drive Multiple Sclerosis Progression
Peeters, L. M., Vanheusden, M., Somers, V. A., Wijmeersch, B. V., Stinissen, P., Broux, B., & Hellings, N. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01160 · Cited by 97
Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis
Pender, M. P., Csurhes, P. A., Lenarczyk, A., Pfluger, C. M., & Burrows, S. R. (2008) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.161018 · Cited by 96
Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex
Chao, M., Ramagopalan, S. V., Herrera, B. M., Lincoln, M. R., Dyment, D. A., Sadovnick, A. D., & Ebers, G. C. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn353 · Cited by 96
Role of Regulatory T Cells in Pathogenesis and Biological Therapy of Multiple Sclerosis
Buc, M. (2013) · Mediators of Inflammation · doi:10.1155/2013/963748 · Cited by 98
Allopregnanolone and neuroinflammation: a focus on multiple sclerosis
Noorbakhsh, F., Baker, G. B., & Power, C. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00134 · Cited by 95
Astrocyte, the star avatar: redefined
Seth, P., & Koul, N. (2008) · Journal of Biosciences · doi:10.1007/s12038-008-0060-5 · Cited by 105
Regulatory Functions of Natural Killer Cells in Multiple Sclerosis
Groß, C. C., Schulte‐Mecklenbeck, A., Wiendl, H., Marcenaro, E., de Rosbo, N. K., Uccelli, A., & Laroni, A. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00606 · Cited by 97
An autoantibody signature predictive for multiple sclerosis
Zamecnik, C. R., Sowa, G. M., Abdelhak, A., Dandekar, R., Bair, R., Wade, K. J., Bartley, C. M., Kizer, K., Augusto, D. G., Tubati, A., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-02938-3 · Cited by 104
Deciphering complex mechanisms in neurodegenerative diseases: the advent of systems biology
Noorbakhsh, F., Overall, C. M., & Power, C. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.10.003 · Cited by 95
Lipoic acid inhibits expression of ICAM-1 and VCAM-1 by CNS endothelial cells and T cell migration into the spinal cord in experimental autoimmune encephalomyelitis
Chaudhary, P., Marracci, G., & BOURDETTE, D. N. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.03.007 · Cited by 96
Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis
Dhib-Jalbut, S. S. (2007) · Neurology · doi:10.1212/01.wnl.0000275228.13012.7b · Cited by 97
CD4 T cells: Balancing the coming and going of autoimmune-mediated inflammation in the CNS
Dittel, B. N. (2008) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2007.11.010 · Cited by 95
Chapter 4 B Cells and Autoantibodies in the Pathogenesis of Multiple Sclerosis and Related Inflammatory Demyelinating Diseases
McLaughlin, K. A., & Wucherpfennig, K. W. (2008) · Advances in immunology · doi:10.1016/s0065-2776(08)00404-5 · Cited by 93
Synthetic Retinoid AM80 Inhibits Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis
Klemann, C., Raveney, B. J. E., Klemann, A. K., Ozawa, T., von Hörsten, S., Shudo, K., Oki, S., & Yamamura, T. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081084 · Cited by 93
Identification of an IL-27/osteopontin axis in dendritic cells and its modulation by IFN-γ limits IL-17–mediated autoimmune inflammation
Murugaiyan, G., Mittal, A., & Weiner, H. L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002099107 · Cited by 93
Cytotoxic NKG2C+ CD4 T Cells Target Oligodendrocytes in Multiple Sclerosis
Zaguia, F., Saikali, P., Ludwin, S. K., Newcombe, J., Beauseigle, D., McCrea, E., Duquette, P., Prat, A., Antel, J. P., & Arbour, N. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202725 · Cited by 93
IFN-γ Limits Th9-Mediated Autoimmune Inflammation through Dendritic Cell Modulation of IL-27
Murugaiyan, G., Beynon, V., da Cunha, A. P., Joller, N., & Weiner, H. L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200808 · Cited by 93
Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study
Jilek, S., Jaquiéry, E., Hirsch, H. H., Lysandropoulos, A. P., Canales, M., Guignard, L., Schluep, M., Pantaleo, G., & Pasquier, R. D. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70006-5 · Cited by 92
Autophagy, inflammation and neurodegenerative disease
Alirezaei, M., Kemball, C. C., & Whitton, J. L. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07500.x · Cited by 93
Chemokine-Like Receptor-1 Expression by Central Nervous System-Infiltrating Leukocytes and Involvement in a Model of Autoimmune Demyelinating Disease
Graham, K. L., Zabel, B. A., Loghavi, S., Zuniga, L. A., Ho, P. P.-K., Sobel, R. A., & Butcher, E. C. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803435 · Cited by 92
New approaches in the management of multiple sclerosis
Allington, D. R. (2010) · Drug Design Development and Therapy · doi:10.2147/dddt.s9331 · Cited by 92
Blood RNA profiling in a large cohort of multiple sclerosis patients and healthy controls
Nickles, D., Chen, H. P., Li, M. M., Khankhanian, P., Madireddy, L., Caillier, S. J., Santaniello, A., Cree, B., Pelletier, D., Hauser, S. L., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt267 · Cited by 95
Immunology of neuromyelitis optica: a T cell-B cell collaboration
Mitsdoerffer, M., Kuchroo, V., & Korn, T. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12118 · Cited by 91
Myeloperoxidase and Neurological Disorder: A Crosstalk
Pravalika, K., Sarmah, D., Kaur, H., Wanve, M., Saraf, J., Kalia, K., Borah, A., Yavagal, D. R., Dave, K. R., & Bhattacharya, P. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00462 · Cited by 91
Peroxisome Proliferator-Activated Receptor-γ Agonists Suppress the Production of IL-12 Family Cytokines by Activated Glia
Xu, J., & Drew, P. D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1904 · Cited by 91
Therapeutic role of beta-interferons in multiple sclerosis
Javed, A., & Reder, A. T. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.08.011 · Cited by 91
Critical Requirement of CD11b (Mac-1) on T Cells and Accessory Cells for Development of Experimental Autoimmune Encephalomyelitis
Bullard, D. C., Hu, X., Schoeb, T. R., Axtell, R. C., Raman, C., & Barnum, S. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6327 · Cited by 91
Orphan nuclear receptor NR4A2 expressed in T cells from multiple sclerosis mediates production of inflammatory cytokines
Doi, Y., Oki, S., Ozawa, T., Hohjoh, H., Miyake, S., & Yamamura, T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803454105 · Cited by 91
Th17 cells in inflammation
Kimura, A., & Kishimoto, T. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.10.004 · Cited by 91
The crucial role of mast cells in blood–brain barrier alterations
Ribatti, D. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.05.013 · Cited by 92
Neuroprotection, regeneration and immunomodulation: broadening the therapeutic repertoire in multiple sclerosis
Aktaş, O., Kieseier, B. C., & Hartung, H. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2009.12.002 · Cited by 92
Immune regulation of multiple sclerosis by transdermally applied myelin peptides
Juryńczyk, M., Walczak, A., Jurewicz, A., Jesionek‐Kupnicka, D., Szczepanik, M., & Selmaj, K. W. (2010) · Annals of Neurology · doi:10.1002/ana.22219 · Cited by 90
Recognition of Conserved Amino Acid Motifs of Common Viruses and Its Role in Autoimmunity
Sospedra, M., Zhao, Y., Hausen, H. Z., Muraro, P. A., Hamashin, C., de Villiers, E., Pinilla, C., & Martinꝉ, R. (2005) · PLoS Pathogens · doi:10.1371/journal.ppat.0010041 · Cited by 90
Self-citation
Th22 cells are expanded in multiple sclerosis and are resistant to IFN-β
Rolla, S., Bardina, V., Mercanti, S. F. D., Quaglino, P., Palma, R. D., Gned, D., Brusa, D., Durelli, L., Novelli, F., & Clerico, M. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.5a0813-463rr · Cited by 90
The role of TAM family receptors and ligands in the nervous system: From development to pathobiology
Shafit‐Zagardo, B., Gruber, R. C., & DuBois, J. C. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.03.002 · Cited by 89
Cyclotides Suppress Human T-Lymphocyte Proliferation by an Interleukin 2-Dependent Mechanism
Gründemann, C., Thell, K., Lengen, K., Garcia‐Käufer, M., Huang, Y., Huber, R., Craik, D. J., Schabbauer, G., & Gruber, C. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068016 · Cited by 88
Nuclear Receptor NR4A2 Orchestrates Th17 Cell-Mediated Autoimmune Inflammation via IL-21 Signalling
Raveney, B. J. E., Oki, S., & Yamamura, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056595 · Cited by 89
High-Density Peptide Microarray Analysis of IgG Autoantibody Reactivities in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients
Hecker, M., Fitzner, B., Wendt, M., Lorenz, P., Flechtner, K., Steinbeck, F., Schröder, I., Thiesen, H., & Zettl, U. K. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.051664 · Cited by 90
Smad7 in T cells drives T helper 1 responses in multiple sclerosis and experimental autoimmune encephalomyelitis
Kleiter, I., Song, J., Lukas, D., Hasan, M., Neumann, B. H., Croxford, A. L., Pedré, X., Hövelmeyer, N., Yogev, N., Mildner, A., et al. (2010) · Brain · doi:10.1093/brain/awq039 · Cited by 88
Pathogenic CD8 T Cells in Multiple Sclerosis and Its Experimental Models
Huseby, E. S., Huseby, P. G., Shah, S., Smith, R. L., & Stadinski, B. D. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00064 · Cited by 87
Epstein-Barr virus infection of human brain microvessel endothelial cells: A novel role in multiple sclerosis
Casiraghi, C., Dorovini‐Zis, K., & Horwitz, M. S. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.08.003 · Cited by 87
Learning from Nature: Pregnancy Changes the Expression of Inflammation-Related Genes in Patients with Multiple Sclerosis
Gilli, F., Lindberg, R. L. P., Valentino, P., Marnetto, F., Malucchi, S., Sala, A., Capobianco, M. A. N., Sapio, A. D., Sperli, F., Kappos, L., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008962 · Cited by 89
Gender differences in circulating levels of neutrophil extracellular traps in serum of multiple sclerosis patients
Tillack, K., Naegele, M., Haueis, C., Schippling, S., Wandinger, K., Martinꝉ, R., & Sospedra, M. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.05.004 · Cited by 88
Self-citation
Highly reactive anti-myelin oligodendrocyte glycoprotein antibodies differentiate demyelinating diseases from viral encephalitis in children
Lalive, P. H., Häusler, M., Maurey, H., Mikaeloff, Y., Tardieu, M., Wiendl, H., Schroeter, M., Hp, H., Kieseier, B., & Menge, T. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510389220 · Cited by 86
Structure of a TCR with high affinity for self‐antigen reveals basis for escape from negative selection
Yin, Y., Li, Y., Kerzic, M. C., Martinꝉ, R., & Mariuzza, R. A. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.21 · Cited by 86
Self-citation
Effector and regulatory B cells in Multiple Sclerosis
Staun-Ram, E., & Miller, A. (2017) · Clinical Immunology · doi:10.1016/j.clim.2017.04.014 · Cited by 90
Kappa opioid receptor activation alleviates experimental autoimmune encephalomyelitis and promotes oligodendrocyte-mediated remyelination
Du, C., Duan, Y., Wei, W., Cai, Y., Chai, H., Lv, J., Du, X., Zhu, J., & Xie, X. (2016) · Nature Communications · doi:10.1038/ncomms11120 · Cited by 86
Analysis of miRNA signatures in CSF identifies upregulation of miR-21 and miR-146a/b in patients with multiple sclerosis and active lesions
Martín, M. M., Reverter‐Branchat, G., Robles‐Cedeño, R., Buxó, M., Ortega, F. J., Gómez, I., Tomàs-Roig, J., Celarain, N., Villar, L. M., Perkal, H., et al. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1590-5 · Cited by 85
MyelStones: the executive roles of myelin basic protein in myelin assembly and destabilization in multiple sclerosis
Vassall, K. A., Bamm, V. V., & Harauz, G. (2015) · Biochemical Journal · doi:10.1042/bj20150710 · Cited by 86
Glucocorticoids in the control of neuroinflammation
Tischner, D., & Reichardt, H. M. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.03.007 · Cited by 85
Assessing tissue damage in multiple sclerosis: a biomarker approach
Burman, J., Zetterberg, H., Fransson, M., Loskog, A., Raininko, R., & Fagius, J. (2014) · Acta Neurologica Scandinavica · doi:10.1111/ane.12239 · Cited by 85
Pathological differences between white and grey matter multiple sclerosis lesions
Prins, M., Schul, E., Geurts, J. J. G., van der Valk, P., Drukarch, B., & van Dam, A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12841 · Cited by 89
Structural basis for self‐recognition by autoimmune T ‐cell receptors
Yin, Y., Li, Y., & Mariuzza, R. A. (2012) · Immunological Reviews · doi:10.1111/imr.12002 · Cited by 88
Extra virgin olive oil: a key functional food for prevention of immune-inflammatory diseases
Aparicio‐Soto, M., Sánchéz‐Hidalgo, M., Rosillo, M. Á., Castejón, M. L., & Alarcón‐de‐la‐Lastra, C. (2016) · Food & Function · doi:10.1039/c6fo01094f · Cited by 85
Modelling of multiple sclerosis: lessons learned in a non-human primate
Hart, B. A. ‘., Laman, J. D., Bauer, J., Blezer, E. L. A., van Kooyk, Y., & Hintzen, R. Q. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00879-8 · Cited by 85
Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis
Christensen, J. R., Börnsen, L. S., Hesse, D., Krakauer, M., Sørensen, P. S., Søndergaard, H. B., & Sellebjerg, F. T. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-215 · Cited by 86
Olive Oil: Nutritional Applications, Beneficial Health Aspects and its Prospective Application in Poultry Production
Bilal, R. M., Liu, C., Zhao, H., Wang, Y., Farag, M. R., Alagawany, M. M., Hassan, F., Elnesr, S. S., Elwan, H. A. M., Qiu, H., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.723040 · Cited by 84
Natural killer cells and their receptors in multiple sclerosis
Kaur, G., Trowsdale, J., & Fugger, L. H. (2012) · Brain · doi:10.1093/brain/aws159 · Cited by 89
Brazilian experience with two conditioning regimens in patients with multiple sclerosis: BEAM/horse ATG and CY/rabbit ATG
Hamerschlak, N., Rodrigues, M., Moraes, D. A., Oliveira, M. C., Stracieri, A. B. P. L., Pieroni, F., Barros, G. M. N., Madeira, M. I. A., Simões, B. P., Barreira, A. A., et al. (2009) · Bone Marrow Transplantation · doi:10.1038/bmt.2009.127 · Cited by 84
Structural properties of proteins specific to the myelin sheath
Kursula, P. (2006) · Amino Acids · doi:10.1007/s00726-006-0479-7 · Cited by 84
Microglia-mediated neuroinflammation is an amplifier of virus-induced neuropathology
Sarma, J. D. (2013) · Journal of NeuroVirology · doi:10.1007/s13365-013-0188-4 · Cited by 87
A β-Lactam Antibiotic Dampens Excitotoxic Inflammatory CNS Damage in a Mouse Model of Multiple Sclerosis
Melzer, N., Meuth, S. G., Torres‐Salazar, D., Bittner, S., Zozulya, A. L., Weidenfeller, C., Kotsiari, A., Stangel, M., Fahlke, C. M., & Wiendl, H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003149 · Cited by 85
miR-155-3p Drives the Development of Autoimmune Demyelination by Regulation of Heat Shock Protein 40
Mycko, M. P., Cichalewska, M., Cwiklinska, H., & Selmaj, K. W. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2830-15.2015 · Cited by 88
Helminth therapy and multiple sclerosis
Fleming, J. O. (2013) · International Journal for Parasitology · doi:10.1016/j.ijpara.2012.10.025 · Cited by 84
Dendritic cells in brain diseases
Ludewig, P., Gallizioli, M., Urra, X., Behr, S., Brait, V. H., Gelderblom, M., Magnus, T. U., & Planas, A. M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.11.003 · Cited by 86
Obeticholic acid, a synthetic bile acid agonist of the farnesoid X receptor, attenuates experimental autoimmune encephalomyelitis
Ho, P. P.-K., & Steinman, L. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1524890113 · Cited by 85
Without nerves, immunology remains incomplete –in vivo veritas
Shepherd, A. J., Downing, J. R., & Miyan, J. A. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02223.x · Cited by 83
Increased plasma levels of brain derived neurotrophic factor (BDNF) after multiple sclerosis relapse
Comini-Frota, E. R., Rodrigues, D. H., Donadi, E. A., Brum, D. G., Maciel, D. R. K., & Teixeira, A. L. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.05.057 · Cited by 82

Authors: Sospedra, M., & Martin, R.
Affiliations: National Institutes of Health (US)
Cellular Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892-1400;
ORCID: Sospedra, Mireia
Venue: Annual Review of Immunology
Publisher: Annual Reviews
Published: 2005-04-01
Volume: 23
Issue: 1
Pages: 683-747
ISSN: 0732-0582 (ISSN-L)
1545-3278
DOI: 10.1146/annurev.immunol.23.021704.115707
OpenAlex: W2113291839
Cited by: 2,149
References: 362
Citations by year: 2026: 27 · 2025: 43 · 2024: 62 · 2023: 64 · 2022: 69 · 2021: 72 · 2020: 78 · 2019: 84 · 2018: 71 · 2017: 110 · 2016: 107 · 2015: 149 · 2014: 133 · 2013: 144 · 2012: 120
FWCI: 19.06
Type: journal article
Language: en
Open access: closed
Locations: Annual Review of Immunology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
Keywords: multiple sclerosis, autoimmunity, CD4+ T cells, Th1 cells, Th2 cells, regulatory T cells, natural killer cells, CD8+ T cells, complement system, autoantibodies, innate immunity, viral triggers, genetic susceptibility, relapsing-remitting disease, chronic progressive disease, central nervous system, neuroimmune interactions
MeSH terms: Autoantibodies, Autoantigens, Central Nervous System, HLA Antigens, Humans, Immunity, Innate, Immunogenetics, Infections, Multiple Sclerosis, Myelin Proteins, T-Lymphocyte Subsets, Cytokines, Models, Immunological, Molecular Mimicry, Chemokines, Genomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

IMMUNOLOGY OF MULTIPLE SCLEROSIS

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks